| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.5B | $0.5B | $0.5B | $0.6B | $0.4B | $0.5B | $0.4B |
| EPS (Basic) | $9.17 | $8.14 | $8.02 | $7.68 | $8.95 | $6.19 | $7.03 | $1.50 |
| EPS (Diluted) | $9.17 | $8.14 | $8.02 | $7.68 | $8.95 | $6.19 | $7.03 | $1.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $52.2B | $49.7B | $49.8B | $47.8B | $50.2B | $46.7B | $42.2B | $38.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $2.8B | $1.2B | $1.3B | $1.1B |
| Total Liabilities | $46.3B | $44.1B | $44.7B | $43.1B | $44.9B | $41.4B | $37.3B | $33.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.9B | $5.5B | $5.1B | $4.7B | $5.4B | $5.3B | $4.9B | $4.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $1.4B | $0.1B | $5.1B | $-3.7B | $-0.4B | $-0.5B | $-0.6B |
| Investing Cash Flow | $-1.5B | $-0.5B | $-1.8B | $-4.6B | $2.6B | $-2.5B | $-2.3B | $-1.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.0B | $-0.9B | $1.7B | $-2.0B | $2.7B | $2.8B | $2.9B | $1.2B |